CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment
NCT00604357
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
End Stage Liver Disease
Impaired Renal Function
Interventions
DRUG:
anti-CD 25 mAb, Sirolimus, MMF
Sponsor
University of Regensburg